Cost-effectiveness of Xpert®MTB/RIF in the diagnosis of tuberculosis: pragmatic study

Cost-effectiveness of Xpert®MTB/RIF in the diagnosis of tuberculosis: pragmatic study

Abstract INTRODUCTION: The intensification of research and innovation with the creation of networks of rapid and effective molecular tests as strategies for the end of tuberculosis are essential to avoid late diagnosis and for the eradication of the disease. We aimed to evaluate the cost-effective...

Full description

Bibliographic Details
Main Authors:	Suely Conceição Alves da Silva, Maria Claudia Vater, Daniela Maria de Paula Ramalho, Isabela Neves de Almeida, Silvana Spíndola de Miranda, Afrânio Kritski
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Medicina Tropical (SBMT) 2021-02-01
Series:	Revista da Sociedade Brasileira de Medicina Tropical
Subjects:	Multidrug-resistant tuberculosis Cost-effectiveness New diagnostics Xpert MTB/RIF Innovation
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822021000100311&tlng=en

Similar Items

Diagnostic Performance of Xpert MTB/RIF Ultra Compared with Predecessor Test, Xpert MTB/RIF, in a Low TB Incidence Setting: a Retrospective Service Evaluation
by: Mary Mansfield, et al.
Published: (2022-06-01)

Use of Xpert MTB/RIF for diagnosis of pediatric tuberculosis in Indonesia
by: Rina Triasih, et al.
Published: (2020-07-01)

Xpert MTB/RIF Ultra assay for the detection of Mycobacterium tuberculosis in people with negative conventional Xpert MTB/RIF but chest imaging suggestive of tuberculosis in Dhaka, Bangladesh
by: Samanta Biswas, et al.
Published: (2022-01-01)

Comparison of Interpretation between Pyrosequencing and Xpert MTB/RIF Assay in Multidrug-Resistant Tuberculosis
by: Linda Choerunnisa, et al.
Published: (2020-12-01)

Evaluation of Xpert MTB/RIF assay performance in the diagnosis of abdominal tuberculosis
by: Suraj Kumar, et al.
Published: (2017-04-01)

Implementation of the Xpert MTB/RIF assay for tuberculosis in Mongolia: a qualitative exploration of barriers and enablers
by: Nicole L. Rendell, et al.
Published: (2017-07-01)

Xpert MTB/RIF Ultra Assay Using Stool: an Effective Solution for Bacilli Identification from Adult Pulmonary Tuberculosis Suspects without Expectorated Sputum
by: Xia Yu, et al.
Published: (2023-08-01)

The transition to Xpert MTB/RIF ultra: diagnostic accuracy for pulmonary tuberculosis in Kampala, Uganda
by: A. Andama, et al.
Published: (2021-01-01)

A feasibility study of the Xpert MTB/RIF test at the peripheral level laboratory in China
by: Xichao Ou, et al.
Published: (2015-02-01)

Study of diagnostic utility of Xpert MTB/Rif test on pleural fluid in the evaluation of patients presenting with Pleural Tuberculosis in Nepal
by: Deebya Raj Mishra, et al.
Published: (2022-01-01)

Xpert MTB/RIF Ultra outperformed the Xpert assay in tuberculosis lymphadenitis diagnosis: a prospective head-to-head cohort study
by: Xia Yu, et al.
Published: (2022-09-01)

An evaluation of false-positive rifampicin resistance on the Xpert MTB/RIF
by: Yeliz Tanriverdi Cayci, et al.

Diagnostic performance of GeneXpert MTB/RIF in detecting MTB in smear-negative presumptive TB patients
by: Raksha Rimal, et al.
Published: (2022-04-01)

Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia
by: Julia V. Ershova, et al.
Published: (2020-07-01)

Evaluation of Xpert MTB/RIF and MODS assay for the diagnosis of pediatric tuberculosis
by: Nhu Nguyen Thi Quynh, et al.
Published: (2013-01-01)

High prevalence of multidrug-resistant tuberculosis among patients with rifampicin resistance using GeneXpert Mycobacterium tuberculosis/rifampicin in Ghana
by: Justice K Boakye-Appiah, et al.
Published: (2016-01-01)

Utility of Xpert MTB/RIF Assay for Diagnosis of Pediatric Tuberculosis Under Programmatic Conditions in India
by: Rakesh Yadav, et al.
Published: (2020-01-01)

Difficulties with the implemented xpert MTB/RIF for determining diagnosis of pulmonary and extrapulmonary tuberculosis in adults and children
by: Ni Made Mertaniasih, et al.
Published: (2020-05-01)

Diagnostic value of tNGS vs Xpert MTB/RIF in childhood TB
by: Huiwen Zheng, et al.
Published: (2024-01-01)

Diagnostic accuracy of GeneXpert MTB/RIF in musculoskeletal tuberculosis: High sensitivity in tissue samples of HIV-infected and HIV-uninfected patients
by: M Held, et al.
Published: (2017-10-01)

Role of empiric treatment in hospitalized patients with Xpert MTB/RIF-negative presumptive pulmonary tuberculosis: A prospective cohort study
by: Wakjira Kebede, et al.
Published: (2020-08-01)

XPERT MTB/RIF TEST FOR THE DIAGNOSIS OF TUBERCULOSIS AND RIFAMPICIN RESISTANCE: RESULTS OF ITS INTRODUCTION IN THE KYRGYZ REPUBLIC
by: A. D. Adambekova, et al.
Published: (2014-01-01)

Rolling out Xpert MTB/RIF® for tuberculosis detection in HIV-positive populations: An opportunity for systems strengthening
by: Ishani Pathmanathan, et al.
Published: (2017-03-01)

The Magnitude of MTB and Rifampicin Resistance MTB Using Xpert-MTB/RIF Assay Among Tuberculosis Suspected Patients in Gedeo Zone, Southern Ethiopia
by: Diriba K, et al.
Published: (2021-09-01)

Spot specimen testing with GeneXpert MTB/RIF results compared to morning specimen in a programmatic setting in Cotonou, Benin
by: Faridath Massou, et al.
Published: (2021-09-01)

Apport du Test Xpert MTB/RIF dans le diagnostic et le traitement de la tuberculose.
by: HE Hassan, et al.
Published: (2021-06-01)

Evaluation of GeneXpert MTB/RIF for determination of rifampicin resistance among new tuberculosis cases in west and northwest Iran
by: S. Atashi, et al.
Published: (2017-09-01)

Xpert MTB/RIF assay for diagnosis of extrapulmonary tuberculosis in children: a systematic review and meta-analysis
by: Young Seok Seo, et al.
Published: (2020-01-01)

Pooling sputum testing to diagnose tuberculosis using xpert MTB/RIF and xpert ultra: a cost-effectiveness analysis
by: Vibol Iem, et al.
Published: (2023-05-01)

The diagnostic performance of endobronchial ultrasound with Xpert MTB/RIF Ultra in smear-negative pulmonary tuberculosis
by: Lan Yao, et al.
Published: (2023-02-01)

Xpert MTB/RIF assay for the diagnosis of rifampicin resistance in different regions: a meta-analysis
by: Kaican Zong, et al.
Published: (2019-08-01)

Diagnostic utility of GeneXpert MTB/RIF assay versus conventional methods for diagnosis of pulmonary and extra-pulmonary tuberculosis
by: Asmaa Mohammed Elbrolosy, et al.
Published: (2021-05-01)

Rifampicin susceptibility discordance between Xpert MTB/RIF G4 and Xpert Ultra before MDRT-TB treatment initiation: A case report from Uganda
by: Willy Ssengooba, et al.
Published: (2021-12-01)

Performance of Xpert/MTB/RIF assay for childhood pulmonary tuberculosis among HIV negative children with real world evidence in China
by: Lu Xia, et al.
Published: (2020-11-01)

Performance of Xpert® MTB/RIF in diagnosing tuberculous pleuritis using thoracoscopic pleural biopsy
by: Chengjun Li, et al.
Published: (2020-11-01)

The role of Xpert MTB/RIF using bronchoalveolar lavage fluid in active screening: insights from a tuberculosis outbreak in a junior school in eastern China
by: Qian Wu, et al.
Published: (2023-12-01)

The New Xpert MTB/RIF Ultra: Improving Detection of <italic toggle="yes">Mycobacterium tuberculosis</italic> and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing
by: Soumitesh Chakravorty, et al.
Published: (2017-09-01)

Usefulness of Xpert MTB/RIF Ultra to Rapidly Diagnose Sputum Smear-Negative Pulmonary Tuberculosis Using Bronchial Washing Fluid
by: Jung-Yien Chien, et al.
Published: (2020-09-01)

Diagnostic accuracy of the Xpert MTB/Rif Ultra for tuberculosis adenitis
by: Katherine Antel, et al.
Published: (2020-01-01)

Xpert MTB/RIF Assay for the Diagnosis of Lymph Node Tuberculosis in Children: A Systematic Review and Meta-Analysis
by: Hao-Kai Chen, et al.
Published: (2022-08-01)